Draft clinical study reports from approved material
Novo Nordisk uses Claude in NovoScribe to draft clinical documentation from expert-approved text and study-specific variables. Claude Code helped build the platform. The company reports 90% less writing time for clinical study reports; human review and approval remain part of the process.
Draft: this entry has not yet been human-reviewed. Its summary and extracted facts are AI-assisted. Check the original source before relying on the claims.
For whom
Medical writers at large pharmaceutical companies; clinical and regulatory expertise plus integration support.
Not for
Not suitable for generating final regulatory submissions without expert review.
Brain Score
- Impact
- 1/2
- Evidence
- 1/2
- Reproducibility
- 0/2
- Maturity
- 2/2
- Reach
- 0/2
Five values from 0 to 2. The total has a minimum of 1. A reading aid based on the source, not an independently measured performance result. How the score works
Original source
- Type
- Vendor
- Published
- Data as of
- 2026-10-31
The data date records when this dataset was included in the collection. It is separate from the publication date of the source.